30 April 2020

Safety Alerts Pharmaceutical Products

Reference: CIR-2019-00000096

To all health facilities / all health care practitioners in Dubai's private health sector:

Referring to the above subject, DHA notes all health facilities regarding the Circular issued by the MOHAP for information and adhere to what is stated

• Pharmaceutical safety of pharmaceuticals containing active substance Chlorhexidine 
• Safety alerts Accu-Chek Insight insulin pumps
• Withdrawal & Suspended pharmaceutical product Sedofen Syrup

Thanks in advance for your good co-operation

Drug Control Section

 Health Regulation Sector

DHA

Supporting Documents:

السلامة الدوائية للمستحضرات الدوائية الحاوية على مادة الفعالة Chlorhexidine.pdf:

View Document

تقرير سلامة Accu-Chek Insight insulin pumps.pdf:

View Document

سحب وتعليق تسجيل مستحضر دوائي Sedofen Syrup.pdf:

View Document